Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Barzilai, Jiali Wang, D. Massilon, P. Vuguin, M. Hawkins, L. Rossetti (1997)
Leptin selectively decreases visceral adiposity and enhances insulin action.The Journal of clinical investigation, 100 12
G. Hotamisligil, P. Arner, J. Caro, R. Atkinson, B. Spiegelman (1995)
Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.The Journal of clinical investigation, 95 5
C. Montague, J. Prins, L. Sanders, J. Digby, S. O’Rahilly (1997)
Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.Diabetes, 46 3
D. Carr, K. Utzschneider, R. Hull, K. Kodama, B. Retzlaff, J. Brunzell, J. Shofer, B. Fish, R. Knopp, S. Kahn (2004)
Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.Diabetes, 53 8
H. Koistinen, E. Dusserre, P. Ebeling, P. Vallier, V. Koivisto, H. Vidal (2000)
Subcutaneous adipose tissue expression of plasminogen activator inhibitor‐1 (PAI‐1) in nondiabetic and Type 2 diabetic subjectsDiabetes/Metabolism Research and Reviews, 16
J. Silha, M. Kršek, J. Škrha, P. Sucharda, B. Nyomba, L. Murphy (2003)
Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.European journal of endocrinology, 149 4
M. Garaulet, N. Viguerie, S. Porubský, E. Klimčáková, K. Clément, D. Langin, V. Štich (2004)
Adiponectin gene expression and plasma values in obese women during very-low-calorie diet. Relationship with cardiovascular risk factors and insulin resistance.The Journal of clinical endocrinology and metabolism, 89 2
Yong-ming Liu, J. Lacorte, N. Viguerie, C. Poitou, V. Pelloux, B. Guy-grand, C. Coussieu, D. Langin, A. Basdevant, K. Clément (2003)
Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding.The Journal of clinical endocrinology and metabolism, 88 12
V. Rotter, I. Nagaev, U. Smith (2003)
Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects*Journal of Biological Chemistry, 278
André Tchernof, Eric Poehlman (1998)
Effects of the menopause transition on body fatness and body fat distribution.Obesity research, 6 3
A. Lihn, J. Bruun, G. He, S. Pedersen, P. Jensen, B. Richelsen (2004)
Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjectsMolecular and Cellular Endocrinology, 219
S. Müller, S. Martin, W. Koenig, P. Hanifi-Moghaddam, Wolfgang Rathmann, B. Haastert, G. Giani, T. Illig, B. Thorand, H. Kolb (2002)
Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptorsDiabetologia, 45
E. Kershaw, J. Flier (2004)
Adipose tissue as an endocrine organ.The Journal of clinical endocrinology and metabolism, 89 6
M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, R. Paschke (2002)
Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.Biochemical and biophysical research communications, 290 3
D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher, R. Turner (1985)
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 28
S. Dagogo-Jack, C. Fanelli, D. Paramore, Joy Brothers, M. Landt (1996)
Plasma Leptin and Insulin Relationships in Obese and Nonobese HumansDiabetes, 45
H. Koistinen, J. Bastard, E. Dusserre, P. Ebeling, N. Zegari, F. Andreelli, C. Jardel, M. Donner, L. Meyer, P. Moulin, B. Hainque, J. Riou, M. Laville, V. Koivisto, H. Vidal (2000)
Subcutaneous adipose tissue expression of tumour necrosis factor‐α is not associated with whole body insulin resistance in obese nondiabetic or in type‐2 diabetic subjectsEuropean Journal of Clinical Investigation, 30
E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, R. Bonadonna, M. Muggeo (2003)
Metabolic Syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck StudyInternational Journal of Obesity, 27
Y. Miyazaki, R. Pipek, L. Mandarino, R. DeFronzo (2003)
Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 27 1
Kuo-Chin Huang, Chi-Ling Chen, L. Chuang, Shiuh-Rong Ho, T. Tai, Wei-Shiung Yang (2003)
Plasma adiponectin levels and blood pressures in nondiabetic adolescent females.The Journal of clinical endocrinology and metabolism, 88 9
M. Tai (1994)
A Mathematical Model for the Determination of Total Area Under Glucose Tolerance and Other Metabolic CurvesDiabetes Care, 17
M. Alessi, D. Bastelica, P. Morange, B. Berthet, I. Leduc, M. Verdier, O. Geel, I. Juhan-Vague (2000)
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.Diabetes, 49 8
Y. Park, Shankuan Zhu, L. Palaniappan, S. Heshka, M. Carnethon, S. Heymsfield (2003)
The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.Archives of internal medicine, 163 4
M. Statnick, L. Beavers, L. Conner, H. Corominola, Dwayne Johnson, C. Hammond, R. Rafaeloff-Phail, T. Seng, T. Suter, J. Sluka, E. Ravussin, R. Gadski, J. Caro (2000)
Decreased Expression Of apM1 in Omental and Subcutaneous Adipose Tissue of Humans With Type 2 DiabetesInternational journal of experimental diabetes research, 1
R. Krogh-Madsen, P. Plomgaard, P. Keller, C. Keller, B. Pedersen (2004)
Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue.American journal of physiology. Endocrinology and metabolism, 286 2
Antonios Xydakis, C. Case, Peter Jones, R. Hoogeveen, Mine-Yine Liu, E. Smith, Kathleen Nelson, C. Ballantyne (2004)
Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction.The Journal of clinical endocrinology and metabolism, 89 6
T. Masaki, S. Chiba, Tohru Yasuda, Tetsuo Tsubone, T. Kakuma, I. Shimomura, T. Funahashi, Y. Matsuzawa, H. Yoshimatsu (2003)
Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice.Diabetes, 52 9
Y. Miyazaki, R. Pipek, L. Mandarino, R. DeFronzo (2003)
Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patientsInternational Journal of Obesity, 27
K. Choi, J. Lee, Kw Lee, J. Seo, J. Oh, S.G. Kim, N. Kim, D. Choi, S. Baik (2004)
The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors.European journal of endocrinology, 150 5
E. Tai, T. Lau, S. Ho, A. Fok, Ce Tan (2000)
Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptinInternational Journal of Obesity, 24
H. Koistinen, M. Forsgren, H. Wallberg-Henriksson, J. Zierath (2004)
Insulin action on expression of novel adipose genes in healthy and type 2 diabetic subjects.Obesity research, 12 1
H. Kopp, C. Kopp, A. Festa, K. Krzyzanowska, S. Kriwanek, E. Minar, R. Roka, G. Schernthaner (2003)
Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese PatientsArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 23
G. Hotamisligil, N. Shargill, B. Spiegelman (1993)
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.Science, 259 5091
Christopher Lyon, W. Hsueh (2003)
Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease.The American journal of medicine, 115 Suppl 8A
J. Chan, J. Cheung, C. Stehouwer, J. Emeis, P. Tong, G. Ko, J. Yudkin (2002)
The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modellingInternational Journal of Obesity, 26
J. Friedman, J. Halaas (1998)
Leptin and the regulation of body weight in mammalsNature, 395
M. Schulze, E. Rimm, I. Shai, N. Rifai, F. Hu (2004)
Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes.Diabetes care, 27 7
P. Wilson, W. Kannel, H. Silbershatz, R. D’Agostino (1999)
Clustering of metabolic factors and coronary heart disease.Archives of internal medicine, 159 10
Barbara Nicklas, E. Rogus, E. Colman, Andrew Goldberg (1996)
Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women.The American journal of physiology, 270 1 Pt 1
K. Park, Kyong Park, Mi-Jung Kim, Hye-Soon Kim, Y. Suh, J. Ahn, Kwan Park, Young-Chae Chang, In-kyu Lee (2004)
Relationship between serum adiponectin and leptin concentrations and body fat distribution.Diabetes research and clinical practice, 63 2
Maria Solano, Arlette Perry, Xuewen Wang, Robert Ross, Ronald Goldberg (2003)
Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American womenInternational Journal of Obesity, 27
(2002)
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation, 106 25
M. Schwartz, R. Prigeon, S. Kahn, Marjery Nicolson, J. Moore, Andrew Morawiecki, E. Boyko, D. Porte (1997)
Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different MechanismsDiabetes Care, 20
Y. Matsuzawa, T. Funahashi, S. Kihara, I. Shimomura (2004)
Adiponectin and Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 24
P. Kern, M. Saghizadeh, J. Ong, R. Bosch, R. Deem, R. Simsolo (1995)
The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.The Journal of clinical investigation, 95 5
Adipose tissue is a major source of inflammatory and thrombotic cytokines. This study investigated the relationship of abdominal subcutaneous adipose tissue cytokine gene expression to body composition, fat distribution, and metabolic risk during obesity. We determined body composition, abdominal fat distribution, plasma lipids, and abdominal subcutaneous fat gene expression of leptin, TNF-α, IL-6, PAI-1, and adiponectin in 20 obese, middle-aged women (BMI, 32.7 ± 0.8 kg/m 2 ; age, 57 ± 1 yr). A subset of these women without diabetes ( n = 15) also underwent an OGTT. In all women, visceral fat volume was negatively related to leptin ( r = –0.46, P < 0.05) and tended to be negatively related to adiponectin ( r = –0.38, P = 0.09) gene expression. Among the nondiabetic women, fasting insulin ( r = 0.69, P < 0.01), 2-h insulin ( r = 0.56, P < 0.05), and HOMA index ( r = 0.59, P < 0.05) correlated positively with TNF-α gene expression; fasting insulin ( r = 0.54, P < 0.05) was positively related to, and 2-h insulin ( r = 0.49, P = 0.06) tended to be positively related to, IL-6 gene expression; and glucose area ( r = –0.56, P < 0.05) was negatively related to, and insulin area ( r = –0.49, P = 0.06) tended to be negatively related to, adiponectin gene expression. Also, adiponectin gene expression was significantly lower in women with vs. without the metabolic syndrome (adiponectin- -actin ratio, 2.26 ± 0.46 vs. 3.31 ± 0.33, P < 0.05). We conclude that abdominal subcutaneous adipose tissue expression of inflammatory cytokines is a potential mechanism linking obesity with its metabolic comorbidities. adipose cytokine; visceral fat; glucose; insulin Address for reprint requests and other correspondence: T. You, Section on Gerontology and Geriatric Medicine, Wake Forest Univ. School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157 (E-mail: tyou@wfubmc.edu )
AJP - Endocrinology and Metabolism – The American Physiological Society
Published: Apr 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.